|
All patients (n = 409)
|
Level 1 (n = 208)
|
Level 2 (n = 75)
|
Level 3 (n = 126)
|
p-value
|
---|
Laboratory findings
|
Hb
|
129·2 ± 20·7
|
126·6 ± 21·8
|
125·0 ± 21·6
|
135·9 ± 16·5
|
< 0·001
|
WCC
|
7·0 (5·4–9·4)
|
7·2 (5·4–10·0)
|
6·5 (5·0–9·1)
|
7·1 (5·6–9·5)
|
0·23
|
ANC
|
5·4 (4·0–8·0)
|
5·7 (4·0–8·9)
|
5·1 (3·9–7·8)
|
5·6 (4·2–8·3)
|
0·38
|
Lymphocyte count
|
0·8 (0·5–1·1)
|
0·7 (0·5–1·1)
|
0·7 (0·5–1·0)
|
0·8 (0·6–1·1)
|
0·12
|
Na2+
|
138 (136–141)
|
140 (136–145)
|
137 (135·8–140)
|
137 (135–139)
|
< 0·001
|
K+
|
4·0 (3·7–4·4)
|
4·0 (3·7–4·5)
|
4·2 (3·7–4·5)
|
3·9 (3·7–4·2)
|
0·034
|
Creatinine
|
81 (63–117)
|
95 (68–143)
|
86·5 (65·8–129·5)
|
74 (60·3–89·8)
|
< 0·001
|
CRP
|
90 (45–169)
|
77·5 (34·8–159·8)
|
106 (72·3–187·3)
|
110 (68–192)
|
0·001
|
Ddimer
|
467 (258·5–1035·3)
|
496 (266–1978)
|
671 (387–1042)
|
373 (223–924)
|
0·068
|
hsTNI
|
20·5 (8·1–60)
|
40·0 (17·2–94·3)
|
25·5 (9·9–70·5)
|
8·5 (4·6–22·2)
|
< 0·001
|
Ferritin
|
460 (220–982)
|
365 (143·8–671·5)
|
510 (261·3–946)
|
674 (338·5–1458)
|
< 0·001
|
Procalcitonin
|
0·15 (0·08–0·38)
|
0·17 (0·08–0·52)
|
0·14 (0·08–0·32)
|
0·15 (0·09–0·40)
|
0·60
|
Clinical observations
|
RR (min−1)
|
22 (18–28)
|
20 (18–28)
|
22·5 (20–28)
|
24 (20–29)
|
0·026
|
O2 saturations (%)
|
94·5 (89–96)
|
95 (90–97)
|
94 (88–96)
|
94 (89–96)
|
0·065
|
Heart rate (min−1)
|
90 (76–103)
|
89 (73–102·8)
|
89 (79–101·3)
|
96 (86–108·5)
|
0·001
|
SBP (mmHg)
|
129·2 ± 23·5
|
130·4 ± 25·5
|
131·2 ± 24·4
|
126·2 ± 18·8
|
0·21
|
Temperature (°C)
|
37·7 ± 1·1
|
37·4 ± 1·1
|
37·7 ± 1·1
|
38·0 ± 1·0
|
< 0·001
|
Chest radiography
|
COVID-19 [n(%)]
|
190 (47·4)
|
61 (29·6)
|
40 (55·6)
|
89 (72·4)
|
< 0·001
|
Indeterminate [n(%)]
|
125 (31·2)
|
79 (38·2)
|
22 (30·6)
|
24 (19·5)
|
Non-COVID-19 [n(%)]
|
86 (21·4)
|
66 (32·0)
|
10 (13·9)
|
10 (8·1)
|
- Hb haemoglobin, WCC white cell count, ANC absolute neutrophil count, Na2+ sodium, K+ potassium, CRP C-reactive protein, hsTNI high-sensitivity troponin-I, RR respiratory rate, O2 oxygen, SBP systolic blood pressure